You are here: Industry Insights > Bausch

News List

Bausch loses Salix president—and turnaround architect—to precision GI company fiercepharma
September 08, 2019
After four years working to turn around Bausch Health's Salix Pharmaceuticals, President Mark McKenna is leaving.
Bausch may have shed the Valeant name, but it still leans on price hikes fiercepharma
August 18, 2019
Bausch Healthcare may have changed its name from Valeant last year, but the company hasn’t gotten away from its often-criticized strategy of leaning on price increases, one analyst says.
Bausch Health buy bankrupt Synergy Pharmaceuticals for $200m pharmafile
December 14, 2018
Bankrupt drug developer Synergy Pharmaceuticals has announced that the company is to be acquired by Canadian speciality pharma firm Bausch Health for approximately $200 million in cash.
Ortho resubmits Duobrii in the US pharmatimes
August 17, 2018
Bausch Health group Ortho Dermatologics has resubmitted an application to market its plaque psoriasis lotion Duobrii in the US.
Bausch Health aims top-seller Xifaxan at new diseases to pump up growth fiercepharma
August 13, 2018
What do you do when you need growth, and one drug is far and away your biggest? Pump up that product as much as you can.